Abiraterone plus olaparib in prostate cancer: a new form of synthetic lethality?

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)860-861
Number of pages2
JournalThe Lancet Oncology
Volume19
Issue number7
DOIs
StatePublished - Jul 2018

ASJC Scopus subject areas

  • Oncology

Cite this